News
-
MRA launches support for more specialized Clinical Trial Support Centres
-
Medical Research Agency creates Polish Clinical Research Network
The Medical Research Agency is creating a new quality in clinical trials. After the first competition for funding of Clinical Research Support Centres has been decided, the Agency's activities are accelerating towards the further development of the Network of Polish Centres. Already at the beginning of 2021, a second competition was launched to support the next Centres. At the same time, the President of the Agency for Medical Research Dr. Radosław Sierpiński signed an agreement on the creation of the first Polish Clinical Research Network.
-
Agreement for the internationalization of medical science
-
Results of the call for research and development activity in the scope of non-commercial clinical research - III round
-
MRA will donate PLN 100 million for research in the area of rare diseases
The Medical Research Agency launches the first programme in Central and Eastern Europe worth PLN 100 million for research and development activities, which will be available to patients affected by a disease considered rare or ultra rare.
-
MRA launches nationwide study of new coronavirus mutation
The Medical Research Agency, on behalf of the Minister of Health, in collaboration with the Malopolska Centre for Biotechnology at the Jagiellonian University, is launching a nationwide study to monitor the genetic variation of the SARS-CoV-2 virus in Poland.
-
Who recovered from COVID-19? A nationwide survey is being launched
Medical Research Agency in cooperation with National Institute of Public Health - PZH on behalf of the Minister of Health launches "Nationwide Sero-epidemiological Study COVID-19: OBSER-CO". The project aims to assess the actual prevalence of SARS-CoV-2 virus in Poland.
-
MRA supported the SARSTer project - testing therapeutic options used in the fight against COVID-19
The Medical Research Agency, on behalf of the Minister of Health, has funded a project of researchers from the Societas Polona Epidemiologrum et Medicorum Contagigosorum (PTEiLChZ) who will test the effectiveness and safety of various COVID-19 therapy options used in Poland since the beginning of the epidemic.
-
We'll know the results of the amantadine study in a few weeks
The Agency for Medical Research, in response to a request from Minister of Health Adam Niedzielski, funded a study on the use of amantadine in preventing progression and treating symptoms of COVID-19. The study aims to confirm whether the incoming reports of the efficacy of a substance previously used to treat Parkinson's also prevents the development of COVID-19.
-
Non-commercial clinical trial of CAR-T therapy with Medical Research Agency funding
Medical Research Agency has signed a contract for the implementation of the project called "Polish Chimeric Antigen Receptor T-cell Network", thanks to which patients in Poland will have access to the most modern treatment methods.